Exact Mass: 592.3165

Exact Mass Matches: 592.3165

Found 500 metabolites which its exact mass value is equals to given mass value 592.3165, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mesobilirubinogen

3-(2-{[3-(2-carboxyethyl)-5-[(4-ethyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methyl}-5-[(3-ethyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl)propanoic acid

C33H44N4O6 (592.3261)

Mesobilirubinogen (also known as I-urobilinogen) is a tetrapyrrole chemical compound that is closely related to two other compounds: urobilinogen (also known as D-urobilinogen) and stercobilinogen (also known as L-urobilinogen). Specifically, urobilinogen can be reduced to form mesobilirubinogen, and mesobilirubinogen can be further reduced to form stercobilinogen. Confusingly, all three of these compounds are frequently collectively referred to as "urobilinogens". Urobilinogen is the parent compound of both stercobilin (the pigment that is responsible for the brown colour of feces) and urobilin (the pigment that is responsible for the yellow colour of urine). Urobilinogen is formed through the microbial degradation of its parent compound bilirubin. Urobilinogen is actually generated through the degradation of heme, the red pigment in hemoglobin and red blood cells (RBCs). RBCs have a life span of about 120 days. When the RBCs have reached the end of their useful lifespan, the cells are engulfed by macrophages and their constituents recycled or disposed of. Heme is broken down when the heme ring is opened by the enzyme known as heme oxygenase, which is found in the endoplasmic reticulum of the macrophages. The oxidation process produces the linear tetrapyrrole known as biliverdin along with ferric iron (Fe3+), and carbon monoxide (CO). In the next reaction, a second methylene group (located between rings III and IV of the porphyrin ring) is reduced by the enzyme known as biliverdin reductase, producing bilirubin. Bilirubin is significantly less extensively conjugated than biliverdin. This reduction causes a change in the colour of the biliverdin molecule from blue-green (vert or verd for green) to yellow-red, which is the colour of bilirubin (ruby or rubi for red). In plasma, virtually all the bilirubin is tightly bound to plasma proteins, largely albumin, because it is only sparingly soluble in aqueous solutions at physiological pH. In the sinusoids, unconjugated bilirubin dissociates from albumin, enters the liver cells across the cell membrane through non-ionic diffusion to the smooth endoplasmatic reticulum. In hepatocytes, bilirubin-UDP-glucuronyltransferase (bilirubin-UGT) adds 2 additional glucuronic acid molecules to bilirubin to produce the more water-soluble version of the molecule known as bilirubin diglucuronide. The bilirubin diglucuronide is transferred rapidly across the canalicular membrane into the bile canaliculi where it is then excreted as bile into the large intestine. The bilirubin is further degraded (reduced) by microbes present in the large intestine to form a colourless product known as urobilinogen. Urobilinogen that remains in the colon can either be reduced to stercobilinogen and finally oxidized to stercobilin, or it can be directly reduced to stercobilin. Some of the urobilinogen produced by the gut bacteria is reabsorbed and re-enters the enterohepatic circulation. This reabsorbed urobilinogen is oxidized and converted to urobilin. The urobilin is processed through the kidneys and then excreted in the urine, which causes the yellowish colour in urine. Urobilinogen is an uribiniloid, the product of bilirubin reduction in multiple sequential reactions. Urobilinogens are colorless chromogens that may in turn be oxidized to respective yellow oxidation products, urobilins. Under normal conditions only small amounts of bilirubin can be found in stools of adults while urobilinoids are predominant bile pigments (50-250 mg/day). Only negligible amounts of fecal urobilinoids are present in the intestinal lumen of infants during the first months of their life, due to undeveloped intestinal microflora capable of reducing bilirubin. This presumably contributes importantly to the pathogenesis of neonatal jaundice. In adults, the urobilinoid production is highly efficient. At times, it is re-excreted in the urine, where it may be later oxidized to urobilin. (PMID: 16504607) [HMDB]

nuatigenin 3-beta-D-glucopyranoside

(20S,22S,25S)-22,25-Epoxyfurost-5-ene-3beta,26-diol 3-O-beta-D-glucoside

C33H52O9 (592.3611)

Debromoaplysiatoxin

Aplysiatoxin, 17-debromo-

C32H48O10 (592.3247)

A member of the class of aplysiatoxins that has the structure of the parent aplysiatoxin, but is lacking the bromo substituent on the benzene ring at the position para to the phenolic hydroxy group. It is a cyanotoxin produced by several species of freshwater and marine cyanobacteria, as well as algae and molluscs. D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D002273 - Carcinogens

Agavoside A

5,7,9,13-tetramethyl-16-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10-one

C33H52O9 (592.3611)

Agavoside A is found in green vegetables. Agavoside A is from the famine food Agave american From the famine food Agave americana. Agavoside A is found in green vegetables.

1,25-Dihydroxyvitamin D3 monoglucuronide

6-[(3-{2-[7a-methyl-1-(6-methylheptan-2-yl)-hexahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexyl)oxy]-3,4,5,6-tetrahydroxyoxane-2-carboperoxoic acid

C33H52O9 (592.3611)

Aplysiatoxin, 17-debromo-

C32H48O10 (592.3247)

Astacin

3,5,5-trimethyl-4-[3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3,4-dioxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

C40H48O4 (592.3552)

3-(N-n-Octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate

3-[2-({2-methoxy-3-[(octadecylcarbamoyl)oxy]propyl phosphono}oxy)ethyl]-1,3-thiazol-3-ium

C28H53N2O7PS (592.3311)

D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

FP-biotin

ethoxy(9-{[5-(5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanamido)pentyl]carbamoyl}nonyl)phosphinoyl fluoride

C27H50FN4O5PS (592.3223)

Hexobendine

3-[Methyl(2-{methyl[3-(3,4,5-trimethoxybenzoyloxy)propyl]amino}ethyl)amino]propyl 3,4,5-trimethoxybenzoic acid

C30H44N2O10 (592.2996)

C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Plazomicin

4-Amino-N-{5-amino-4-[(3-amino-6-{[(2-hydroxyethyl)amino]methyl}-3,4-dihydro-2H-pyran-2-yl)oxy]-2-{[3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy}-3-hydroxycyclohexyl}-2-hydroxybutanimidate

(3S,3S)-7,7,8,8-Tetradehydro-3,3-dihydroxy-beta,beta-carotene-4,4-dione

C40H48O4 (592.3552)

7,8,7,8-Tetradehydroastaxanthin

Ajugamarin B2|ajugamarin B2 ((12S)-6alpha,12,19-triacetoxy-1beta-<(2S)-2-methylbutanoyloxy>-4,18-epoxyneo-clerod-13(14)-en-15,16-olide)|ajugamarin B2 [(12S)-6alpha,12,19-triacetoxy-1beta-((2S)-2-methylbutanoyloxy)-4,18-epoxyneo-clerod-13(14)-en-15,16-olide]

1alpha-(alpha-methyl)-butanoyloxy-2alpha-(alpha-methyl)-propanoyloxy-4beta-hydroxy-9beta-(beta-)furoyloxy-15-acetoxy-beta-dihydroagarofuran|1??-(??-Methyl)-butanoyl-2??-(??-methyl)-propynoyloxy-4??-hydroxy-9??-(??-)furoyloxy-15-acetoxy-??-dihydroagarofuran

C31H44O11 (592.2883)

Berbamine

C37H40N2O5 (592.2937)

C34H36N6O4

C34H36N6O4 (592.2798)

all-trans-beta-carotenetetron-(3.4.3.4)|all-trans-beta-Carotintetron-(3.4.3.4)|astacin|Astacin, 3,4,3,4-Tetraoxo-beta-carotin

C40H48O4 (592.3552)

junceol A

C31H44O11 (592.2883)

Ser Glu Val Lys Met

C24H44N6O9S (592.289)

NCGC00380514-01!(2S,3R,4S,5S,6R)-2-[4,6-dihydroxy-2-nonyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol [IIN-based: Match]

C27H44O14 (592.2731)

Ser-Glu-Val-Lys-Met

C24H44N6O9S (592.289)

YVKAL

Tyr-Val-Lys-Ala-Leu

C29H48N6O7 (592.3584)

YPTVN

Tyr Pro Thr Val Asn

C27H40N6O9 (592.2857)

3-(?-D-Glucopyranosyloxy)-4,6-dihydroxy-2-nonylphenyl ?-D-glucopyranoside

C27H44O14 (592.2731)

OHHdiA-PA

1-(9Z-octadecenoyl)-2-(4-hydroxy-6-carboxy-5E-hexenoyl)-sn-glycero-3-phosphate

C28H49O11P (592.3012)

Colocynthenin F

C32H48O10 (592.3247)

Agavosid A

(25R)-12-oxo-5alpha-spirostan-3beta-yl beta-D-galactopyranoside

C33H52O9 (592.3611)

ST 27:3;O4;Hex

(20S,22S,25S)-22,25-Epoxyfurost-5-ene-3beta,26-diol 3-O-beta-D-glucoside;(20S,22S,25S)-22,25-epoxy-26-hydroxyfurost-5-en-3beta-yl beta-D-glucopyranoside;(20S,22S,25S)-22,25-epoxyfurost-5-ene-3beta,26-diol 3-O-beta-D-glucoside

C33H52O9 (592.3611)

ST 27:2;O3;GlcA

(5Z,7E)-1alpha,3beta-dihydroxy-10-seco-5,7,10(19)-cholestatrien-25-yl beta-D-glucopyranosiduronic acid

C33H52O9 (592.3611)

Astacene

Plazomicin

C25H48N6O10 (592.3432)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

Sparsentan

C32H40N4O5S (592.2719)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist C28313 - Endothelin Receptor Antagonist > C28334 - Endothelin Receptor Type A Antagonist Sparsentan (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively[1].

Ulimorelin hydrochloride

C30H42ClFN4O5 (592.2828)

C78276 - Agent Affecting Digestive System or Metabolism

Astacin

C40H48O4 (592.3552)

(6R)-6-[(1R,3aS,4E,7aR)-4-{(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyloctahydro-1H-inden-1-yl]-2-methylheptan-2-yl beta-D-glucopyranosiduronic acid

C33H52O9 (592.3611)

N-(R-Carboxy-ethyl)-alpha-(S)-(2-phenylethyl)

C37H44N4O3 (592.3413)

hexobendine

C30H44N2O10 (592.2996)

17-Debromoaplysiatoxin

C32H48O10 (592.3247)

D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D002273 - Carcinogens

6-[(3Z)-3-[(2E)-2-[7a-methyl-1-(6-methylheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexyl]oxy-3,4,5,6-tetrahydroxyoxane-2-carboperoxoic acid

C33H52O9 (592.3611)

D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

Yungensin F

C35H44O8 (592.3036)

A natural product found in Elaphoglossum yungense.

Yungensin A

C35H44O8 (592.3036)

A natural product found in Elaphoglossum yungense.

floribundasaponin A

agavoside A

C33H52O9 (592.3611)

A steroid saponin that consists of (25R)-5alpha-spirostan-3beta-ol substituted by an oxo group at position 12 and a beta-D-galactopyranosyl moiety at position 3 via a glycosidic linkage.

calcitriol 25-O-(beta-D-glucuronide)

C40H48O4 (592.3552)

3-{[5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

C33H52O9 (592.3611)

n-[(1r,2r,4s,9r,10s,11r,13s,14r,16s,17r,18s)-16-(acetyloxy)-10-[(1s)-1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

n-[(1r,2r,4s,9r,10s,11r,13s,14r,16s,17r,18s)-16-(acetyloxy)-10-[(1s)-1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

C35H48N2O6 (592.3512)

(3as,3br,5ar,9as,9br,11ar)-7-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O10 (592.3247)

(1r,2r,3as,3br,5ar,7s,9as,9bs,11ar)-7-{[(2r,3r,4s,5s,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

(1r,2r,3as,3br,5ar,7s,9as,9bs,11ar)-7-{[(2r,3r,4s,5s,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O10 (592.3247)

(2e)-n-[(2e,6z,8z)-11-{4-[(2s)-2-[(3s,4r)-4,8-dihydroxy-7-methyl-1-oxo-3,4-dihydro-2-benzopyran-3-yl]propyl]-1,3-oxazol-2-yl}dodeca-2,6,8-trien-1-yl]-3-methoxy-n-methylbut-2-enamide

C34H44N2O7 (592.3148)

6-(furan-3-yl)-16-hydroxy-1,5,10,15-tetramethyl-18-[(2-methylbut-2-enoyl)oxy]-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-11-yl 2-methylbut-2-enoate

C36H48O7 (592.34)

(1s)-2-[(1r,4r,4ar,5s,6r,8s,8ar)-4,8-bis(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2s)-2-methylbutanoate

C31H44O11 (592.2883)

(1s,2s,3s,4r,7s,8z,10r,12s,13r,14s)-2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl (2r)-2-methylbutanoate

C31H44O11 (592.2883)

[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate

[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate; (2S)-2-methylbutanoic acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-1-spiro[decalin-4,2'-oxirane]yl] ester; [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate; (2S)-2-methylbutyric acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-8-[(2S)-2-acetoxy-2-(5-keto-2H-furan-3-yl)ethyl]-4a-(acetoxymethyl)-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] ester

C31H44O11 (592.2883)

{"Ingredient_id": "HBIN003120","Ingredient_name": "[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate","Alias": "[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate; (2S)-2-methylbutanoic acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-4a-(acetoxymethyl)-8-[(2S)-2-acetoxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-1-spiro[decalin-4,2'-oxirane]yl] ester; [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-acetyloxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethyl-spiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] (2S)-2-methylbutanoate; (2S)-2-methylbutyric acid [(1R,4R,4aR,5S,7R,8S,8aR)-5-acetoxy-8-[(2S)-2-acetoxy-2-(5-keto-2H-furan-3-yl)ethyl]-4a-(acetoxymethyl)-7,8-dimethyl-spiro[decalin-4,2'-oxirane]-1-yl] ester","Ingredient_formula": "C31H44O11","Ingredient_Smile": "NA","Ingredient_weight": "592.67","OB_score": "23.87206564","CAS_id": "121449-65-8","SymMap_id": "SMIT09131","TCMID_id": "NA","TCMSP_id": "MOL007754","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5alpha-cinnamoyloxy-9alpha,10beta,13alpha-triacetoxytaxa-4(20),11-diene

5α-cinnamoyloxy-9α,10β,13α-triacetoxytaxa-4(20),11-diene

C35H44O8 (592.3036)

{"Ingredient_id": "HBIN011414","Ingredient_name": "5alpha-cinnamoyloxy-9alpha,10beta,13alpha-triacetoxytaxa-4(20),11-diene","Alias": "5\u03b1-cinnamoyloxy-9\u03b1,10\u03b2,13\u03b1-triacetoxytaxa-4(20),11-diene","Ingredient_formula": "C35H44O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30787;3717","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

ajugamacrin b

C31H44O11 (592.2883)

{"Ingredient_id": "HBIN014974","Ingredient_name": "ajugamacrin b","Alias": "NA","Ingredient_formula": "C31H44O11","Ingredient_Smile": "CCC(C)C(=O)OC(CC1(C(CC(C2(C1C(CCC23CO3)OC(=O)C)COC(=O)C)OC(=O)C)C)C)C4=CC(=O)OC4","Ingredient_weight": "592.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101370736","DrugBank_id": "NA"}

ajugamarin b2

7-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-2,3a,5a-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C31H44O11 (592.2883)

(1r,2r,3as,3br,5ar,7s,9as,9bs,11ar)-7-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

(1r,2r,3as,3br,5ar,7s,9as,9bs,11ar)-7-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O10 (592.3247)

(1s)-1-[(1s,3ar,3bs,5as,7s,9as,9br,11r,11ar)-11-(benzoyloxy)-1,3a,3b,7-tetrahydroxy-9a,11a-dimethyl-dodecahydrocyclopenta[a]phenanthren-1-yl]ethyl benzoate

C35H44O8 (592.3036)

2-acetyl-6-[(8-butanoyl-5,7-dihydroxy-2,2-dimethylchromen-6-yl)methyl]-4-(3,7-dimethylocta-2,6-dien-1-yl)-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one

C35H44O8 (592.3036)

2,10,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl 2-methylbutanoate

C31H44O11 (592.2883)

(2s,6r)-2-[(1r,3as,3bs,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-2-oxo-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-3-one

(2s,6r)-2-[(1r,3as,3bs,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-2-oxo-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-3-one

C33H52O9 (592.3611)

[(1r,3ar,5r,5ar,7r,8r,9ar,9br,10r,11ar)-10-(acetyloxy)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-5,5a,7,8,9b-pentahydroxy-11a-methyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate

C31H44O11 (592.2883)

(1s,3s,4s,5r,7r,8s,9s,10s)-4-(acetyloxy)-5-hydroxy-4,10-dimethyl-9-{[(2z)-2-methylbut-2-enoyl]oxy}-8-{[(2r)-2-methylbutanoyl]oxy}-7-(prop-1-en-2-yl)-11-oxabicyclo[8.1.0]undecan-3-yl (2z)-2-methylbut-2-enoate

(1s,3s,4s,5r,7r,8s,9s,10s)-4-(acetyloxy)-5-hydroxy-4,10-dimethyl-9-{[(2z)-2-methylbut-2-enoyl]oxy}-8-{[(2r)-2-methylbutanoyl]oxy}-7-(prop-1-en-2-yl)-11-oxabicyclo[8.1.0]undecan-3-yl (2z)-2-methylbut-2-enoate

C32H48O10 (592.3247)

[10-(acetyloxy)-1-(5-ethyl-6-methylhept-3-en-2-yl)-5,5a,7,8,9b-pentahydroxy-11a-methyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate

C33H52O9 (592.3611)

n-[(1s,2r,4s,9r,10s,11r,13s,14r,16s,17r,18s,21r)-16-(acetyloxy)-10-[(1s)-1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

n-[(1s,2r,4s,9r,10s,11r,13s,14r,16s,17r,18s,21r)-16-(acetyloxy)-10-[(1s)-1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

C35H48N2O6 (592.3512)

(1s,2s,3r,4r,7s,8z,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl (2s)-2-methylbutanoate

C31H44O11 (592.2883)

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-16'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-16'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C33H52O9 (592.3611)

(1r,3as,3bs,7s,9ar,9bs,11as)-1-[(2s,6r)-7-hydroxy-6-methyl-3-oxoheptan-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one

(1r,3as,3bs,7s,9ar,9bs,11as)-1-[(2s,6r)-7-hydroxy-6-methyl-3-oxoheptan-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one

C33H52O9 (592.3611)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,8's,9's,12's,13's,14'r,16's,18's)-5,9',13'-trimethyl-7'-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,8's,9's,12's,13's,14'r,16's,18's)-5,9',13'-trimethyl-7'-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy]oxane-3,4,5-triol

C33H52O9 (592.3611)

(1's,2s,5r,6r,10'z,12'z,14's,15's,16'z,19'r)-6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaene-3',4-dione

(1's,2s,5r,6r,10'z,12'z,14's,15's,16'z,19'r)-6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaene-3',4-dione

C36H48O7 (592.34)

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-8'-oloxy}oxane-3,4,5-triol

C33H52O9 (592.3611)

(1r,2s,3s,4s,4ar,5s,6r,8s,8ar)-5-[(3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-3,8-bis(acetyloxy)-2-hydroxy-5,6-dimethyl-4-{[(2e)-2-methylbut-2-en-1-yl]oxy}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

(1r,2s,3s,4s,4ar,5s,6r,8s,8ar)-5-[(3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-3,8-bis(acetyloxy)-2-hydroxy-5,6-dimethyl-4-{[(2e)-2-methylbut-2-en-1-yl]oxy}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

C31H44O11 (592.2883)

(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-(hydroxymethyl)-5-(propanoyloxy)-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl tetradecanoate

C29H52O12 (592.3459)

(4r)-2-acetyl-6-[(6-butanoyl-5,7-dihydroxy-2,2-dimethylchromen-8-yl)methyl]-4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one

C35H44O8 (592.3036)

methyl 6-(acetyloxy)-7,12,13a-trihydroxy-5a-(1-hydroxyethyl)-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H48O10 (592.3247)

5,7',9',13'-tetramethyl-16'-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C33H52O9 (592.3611)

n-[16-(acetyloxy)-10-[1-(dimethylamino)ethyl]-11-hydroxy-9,13,18-trimethyl-3,20-dioxahexacyclo[16.2.1.0²,⁴.0⁴,¹⁷.0⁶,¹⁴.0⁹,¹³]henicos-6-en-21-yl]benzenecarboximidic acid

C35H48N2O6 (592.3512)

C29H52O12 (592.3459)

3-{[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

C33H52O9 (592.3611)

(1r,2s,3as,3br,5as,7s,9as,9bs,11ar)-7-{[(2r,3s,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-2,3a,5a-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1r,2s,3as,3br,5as,7s,9as,9bs,11ar)-7-{[(2r,3s,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-2,3a,5a-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C31H44O11 (592.2883)

(6s)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

(6s)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H48O4 (592.3552)

3-(2,4-dihydroxy-6-pentylbenzoyloxy)-5-pentylphenyl 2,4-dihydroxy-6-pentylbenzoate

C35H44O8 (592.3036)

2,9,10-trihydroxy-12-(hydroxymethyl)-4,6,17,17-tetramethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-13-en-8-one

C32H48O10 (592.3247)

(2s,3s,4as,5r,8as)-3-{[(2r,3s,4r,5r,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

(2s,3s,4as,5r,8as)-3-{[(2r,3s,4r,5r,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

(6r)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

(6r)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H48O4 (592.3552)

1-[(3-{4-[(6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl)methyl]phenoxy}-4-methoxyphenyl)methyl]-6-methoxy-3,4-dihydroisoquinoline

C37H40N2O5 (592.2937)

2,9,10,11-tetrahydroxy-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-13-en-8-one

C32H48O10 (592.3247)

(2s)-2-[(1-hydroxy-2-{[(1s,2r)-2-hydroxy-1-{[(1s,2r)-2-hydroxy-1-{[(4s)-2-methyl-5-oxoheptan-4-yl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}-2-methylethylidene)amino]-3-phenylpropanoic acid

C38H40O6 (592.2825)

methyl (2e,4z,6r,7r,8e,10r,11s,12r,14r)-15-(5-amino-2-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl)-11-hydroxy-7-(c-hydroxycarbonimidoyloxy)-6,12-dimethoxy-2,8,10,14-tetramethylpentadeca-2,4,8-trienoate

C30H44N2O10 (592.2996)

C33H52O9 (592.3611)

n-(11-{4-[2-(4,8-dihydroxy-7-methyl-1-oxo-3,4-dihydro-2-benzopyran-3-yl)propyl]-1,3-oxazol-2-yl}dodeca-2,6,8-trien-1-yl)-3-methoxy-n-methylbut-2-enamide

C34H44N2O7 (592.3148)

(4s)-2-hydroxy-4-[(3r,4s)-12-hydroxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-4-yl]-3-isopropyl-7-methyl-8-(4-methylpent-3-en-1-yl)-4h-naphthalen-1-one

(4s)-2-hydroxy-4-[(3r,4s)-12-hydroxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-4-yl]-3-isopropyl-7-methyl-8-(4-methylpent-3-en-1-yl)-4h-naphthalen-1-one

C40H48O4 (592.3552)

6-cyclohexyl-7',15'-dihydroxy-5,6',10',14',16'-pentamethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4',6',8',10',12',16'-hexaene-3',4-dione

C36H48O7 (592.34)

4-[(2s,4s,4as,5s,7s,8ar)-4-[(1e)-2-(4-hydroxyphenyl)ethenyl]-2,7-bis[2-(4-hydroxyphenyl)ethyl]-octahydropyrano[3,2-c]pyran-5-yl]phenol

C38H40O6 (592.2825)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-hydroxy-1,7-dimethyl-4-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydro-1ah-cyclopropa[e]azulene-1-carboxylate

C27H44O14 (592.2731)

(1s,4r,5r,6r,8r,10s,12s,13s,15s,16r,18s,21r)-8-hydroxy-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-15-yl acetate

(1s,4r,5r,6r,8r,10s,12s,13s,15s,16r,18s,21r)-8-hydroxy-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-15-yl acetate

C33H52O9 (592.3611)

(2s,3s,4as,5r,8as)-3-{[(2r,3s,4s,5s,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

(2s,3s,4as,5r,8as)-3-{[(2r,3s,4s,5s,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C33H52O9 (592.3611)

methyl 3-(acetyloxy)-2,13,20,21,25-pentahydroxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate

C32H48O10 (592.3247)

methyl (1s,2s,3s,4r,5r,8r,13s,14s,17s,18r,20r,21r,22r,25s)-3-(acetyloxy)-2,13,20,21,25-pentahydroxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate

methyl (1s,2s,3s,4r,5r,8r,13s,14s,17s,18r,20r,21r,22r,25s)-3-(acetyloxy)-2,13,20,21,25-pentahydroxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate

C32H48O10 (592.3247)

2,12,14-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl 3-methylbutanoate

C31H44O11 (592.2883)

(2s,3r,4r,5s,6s)-2-{[(1r,2r,3as,3br,5ar,7s,9ar,9bs,11ar)-9a-formyl-2,3a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl acetate

(2s,3r,4r,5s,6s)-2-{[(1r,2r,3as,3br,5ar,7s,9ar,9bs,11ar)-9a-formyl-2,3a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl acetate

C31H44O11 (592.2883)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,1ar,4s,4as,7r,7as,7bs)-4-hydroxy-1,7-dimethyl-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydro-1ah-cyclopropa[e]azulene-1-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,1ar,4s,4as,7r,7as,7bs)-4-hydroxy-1,7-dimethyl-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydro-1ah-cyclopropa[e]azulene-1-carboxylate

C27H44O14 (592.2731)

(2s,3as,5ar,7s,9as,11ar)-7-{[(2r,5s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C32H48O10 (592.3247)

2-(hydroxymethyl)-6-[5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]oxane-3,4,5-triol

C33H52O9 (592.3611)